nicotine has been researched along with Communicable Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altman, RB; David, SP; Klein, TE; McDonagh, EM; Tyndale, RF; Wassenaar, C; Whirl-Carrillo, M | 1 |
1 review(s) available for nicotine and Communicable Diseases
| Article | Year |
|---|---|
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.
Topics: Aryl Hydrocarbon Hydroxylases; Caffeine; Communicable Diseases; Cytochrome P-450 CYP2A6; Humans; Neoplasms; Nicotine; Smoking | 2012 |